[
    "{\"step_by_step_thinking\": \"This study is not a case-control study because it is not comparing patients with a disease to those without the disease. It is also not a crossover study because patients are not switching treatments. It is not a randomized clinical trial because patients are not randomly assigned to different treatments. Therefore, it must be an open-labeled clinical trial because all patients know they are receiving the tyrosine kinase inhibitor and are assigned to different doses.\", \"answer_choice\": \"C. Open-labeled clinical trial\"}"
]